When Novo Nordisk announced in December that it would commence studies with oral semaglutide for treating Alzheimer's, the firm expected that this would happen in the course of the first half-year of 2021.
According to database clinicaltrials.gov, Novo Nordisk is now one step closer to starting this process. The firm has registered two studies for the disease, which are currently scheduled to start on May 18.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Fruergaard leveraging experience from Danish partnerships in key roles in Brussels
Experiences from Danish climate partnerships are among the tools that can be leveraged when Novo Nordisk CEO Lars Fruergaard begins stepping up efforts in the life science sector’s central organs in Brussels. ”I’ve been fired up by the intimacy and shared vision we could see in Denmark,” he tells MedWatch.
Stallergenes slapped with injunction
There are still issues with Stallergenes Greer’s factory in Antony, the Agence Nationale de Sécurité du Médicament has concluded.
Overview: Pharma giants and Bavarian Nordic fight over billion-dollar vaccine market
There is currently no approved vaccine for RSV, which causes serious illness and can be deadly for newborns and the elderly. The race to come first to the vaccine market is heating up, while more companies are close to completing phase III studies. Get an overview of their progress here.
Eargo raises USD 100m from investment firm
US-based Eargo, which is run by a Dane, has entered an agreement with an investment firm which is injecting USD 100m into the company.
US authorities expand monkeypox vaccine plan
More Americans will be offered a monkeypox vaccine.
Senior Electronics Engineer 
Commercial Market Data Manager 
Clinical Project Leader/ Sr. Clinical Trial Manager – make a difference and join our mission to bring our IL-22 lead program to patients 
Device Associate Director/Senior Project Leader 
Biomarker Operations Lead 
Senior Manager/Associate Director, Global Regulatory Affairs, CMC 
Global Product Manager - Pulmonology 
Post Market Surveillance Department Manager 
Regulatory Affairs Manager - Maternity Cover 
Senior Project Manager (GMP - Life Science) 
Nordic Medical Advisor 
Chair of the Board 
Principal Scientist – Pharmacology 
Director Regulatory Affairs